Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKSE · HKD · Healthcare · Drug Manufacturers - General
HK$0.345 (-2.82%) as of
Key statistics
- Market cap
- 248.40M
- EPS (TTM)
- -0.070
- Dividend yield
- 0.00%
- 52-week range
- 0.300 – 3.260
- Beta
- 0.20
- Revenue (TTM)
- 198.95M
- Profit margin
- -21.07%
- Volume
- 795.00k
About Modern Chinese Medicine Group Co., Ltd.
Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines in the People's Republic of China. It provides vigour and vitality supplement, circulation enhancement pills, cardiotonic enhancement capsules, kidney invigoration pill, heart wellness capsules, menstrual discomfort relief, liver detox tablets, additional ingredient Huoxiang Zheng Qi pill, liver-dispersing and stomach regulating pills, and fever- removing and detoxification pills. The company offers its products as therapeutics for the treatment of qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and symptoms of COVID-19 and similar illnesses. It also provides business support, technical, and consulting services. The company serves elderlies and middle-aged customers. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Chengde, China
- Employees
- 189
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.